EPS Bio Technology Corp. announced earnings results for the second quarter ended June 30, 2019. For the second quarter, the company announced sales was TWD 120.117 million compared to TWD 122.135 million a year ago. Operating income was TWD 3.985 million compared to TWD 7.413 million a year ago. Net income was TWD 4.991 million compared to TWD 15.389 million a year ago. Basic earnings per share was TWD 0.21 compared to TWD 0.65 a year ago. For the half year, sales was TWD 220.020 million compared to TWD 191.570 million a year ago. Operating income was TWD 8.411 million compared to operating loss of TWD 11.934 million a year ago. Net income was TWD 8.499 million compared to net loss of TWD 6.777 million a year ago. Basic earnings per share was TWD 0.36 compared to basic loss per share of TWD 0.28 a year ago.